m+Medelevator.RU
← Поиск публикаций
Anticancer research · 2025

Outcomes of Scapular Osteosarcoma.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Garayua-Cruz Leilani, Broida Samuel E, Robinson Steven I, Okuno Scott H, Ho Thanh P, Siontis Brittany L, Sherman Courtney E, Goulding Krista A, Houdek Matthew T

Аннотация

BACKGROUND/AIM: Scapular osteosarcoma is a rare malignancy, and the understanding of its optimal treatment strategies and long-term outcomes remains limited. The purpose of the current study was to evaluate our institutional experience.

PATIENTS AND METHODS: We reviewed 14 patients (8 females, 5 males; mean age 44±17 years) treated for scapular osteosarcoma from 1985 to 2022. Tumors were confirmed histologically and treated with a multidisciplinary approach, including chemotherapy and surgery with a median follow-up of 10 years.

RESULTS: Surgical complications occurred in eight patients, leading to repeat procedures in four. Complications were associated with the use of implants or allografts (p<0.01). Mean shoulder forward elevation and external rotation at follow-up were 42±61° and 12±16°, with a mean MSTS93 score of 61±19%. The 10-year disease-specific survival rates was 76%. Local recurrence was associated with worse survival (HR=13.19, p=0.04).

CONCLUSION: Scapular osteosarcoma is rare, and with multidisciplinary management, local control is essential to patient survival.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты